Exchange: NASDAQ·
OPTN logo

OPTNOptiNose Inc

$0.00
$0.00
(0.00%)
Today
Reported EarningsMar 26
Vol860,961.00
News
all
press releases
News Placeholder
OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates
Zacks
News Placeholder
Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Lags Revenue Estimates
Zacks
News Placeholder
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Tops Revenue Estimates
chainwire
News Placeholder
Optinose Shares Soar After Merger Agreement With Paratek Pharmaceuticals: Retail Sentiment Takes Flight
Paratek will acquire Optinose's outstanding shares for $9 apiece in cash, representing a 50% premium to the stock’s closing trading price of $6 on March 19, and up to $5 per share in contingent value rights if XHANCE achieves certain net revenue milestones.
Stocktwits
<
...
1
>

Advertisement|Remove ads.